Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Oral Vaccine Market Growth From $4.34 Billion In 2026 To $6.28 Billion By 2030 At A CAGR Of 9.7%
The oral vaccine market has demonstrated strong growth in recent years. It is projected to increase from $3.95 billion in 2025 to $4.35 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.0%. This historical expansion can be linked to the prevalence of vaccine-preventable diseases, a growing understanding of immunization benefits, governmental vaccination programs, the development of oral polio and cholera vaccines, and the expansion of hospital and clinic vaccination initiatives.
The oral vaccine market is projected to experience robust expansion over the coming years. This market is anticipated to reach $6.29 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.7%. Factors contributing to this growth during the forecast period include the introduction of innovative oral vaccines (such as DNA, RNA, and VLP types), the broadening of worldwide immunization initiatives, the incorporation of digital health and monitoring solutions, increased funding for vaccine research and development, and a heightened emphasis on vaccinations for adults and travelers. Key trends anticipated during the forecast period involve the growing acceptance of oral vaccines for childhood immunization, a greater focus on preventative healthcare and large-scale vaccination efforts, the creation of live attenuated and subunit oral vaccines, the scaling up of government-supported immunization campaigns, and the incorporation of cold chain and logistics advancements for vaccine delivery.
Get A Free Sample Report With In-Depth Market Insights:
Oral Vaccine Market Growth Drivers: What’s Behind The Acceleration?
The increasing occurrence of infectious diseases is anticipated to fuel the expansion of the oral vaccine market in the future. These diseases are conditions resulting from detrimental microorganisms, including bacteria, viruses, fungi, or parasites, capable of spreading among people or via environmental pathways. The surge in infectious diseases stems from heightened global travel, facilitating the swift translocation of individuals and disease-causing agents across national boundaries, thus hastening the global dissemination of infections. Oral vaccines prove advantageous against infectious diseases by stimulating mucosal immunity within the gut, a critical entry point for numerous pathogens, consequently providing robust protection directly where infections begin. For example, as reported by the UK-based government body, the Health Security Agency, in May 2025, England experienced an 11.0% rise in reported tuberculosis (TB) cases in 2023 compared to the previous year, 2022. Consequently, the escalating incidence of infectious diseases is indeed stimulating the expansion of the oral vaccine market.
Oral Vaccine Market Segment Trends And Revenue Contributors
The oral vaccine market covered in this report is segmented –
1) By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Other Vaccine Types
2) By Application: Polio, Cholera, Other Applications
3) By End-User: Hospital , Clinics, Government Organization, Other End-Users
Subsegments:
1) By Live Attenuated Vaccines: Oral Polio Vaccine (OPV), Rotavirus Vaccine, Oral Typhoid Vaccine, Oral Cholera Vaccine
2) By Inactivated Vaccines: Inactivated Polio Vaccine (IPV), Inactivated Cholera Vaccine, Inactivated Hepatitis A Vaccine
3) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Vaccines, Conjugate Vaccines
4) By Other Vaccine Types: Virus-Like Particle (VLP) Vaccines, Recombinant Vector Vaccines
Oral Vaccine Market Trends: What’s Defining The Industry’s Next Phase?
Major companies operating in the oral vaccine market are actively developing innovative solutions, such as advanced oral pill vaccines, to elevate immune responses and simplify delivery. A second-generation pill-based oral vaccine is engineered to improve its ability to provoke an immune response, broaden the scope of protection, and streamline large-scale immunization efforts, removing the need for injections or refrigerated storage. For instance, in March 2025, Vaxart Inc., a U.S.-based biotechnology company, announced the commencement of a Phase 1 clinical trial for its second-generation oral norovirus vaccine, delivered in a pill formulation. This trial will assess the enhanced immune responses and safety features of the updated formulations, aiming to meet the ongoing global demand for accessible and effective norovirus immunization. The pill format overcomes obstacles associated with injectable vaccines and supports rapid, extensive distribution, particularly during outbreaks.
Oral Vaccine Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the oral vaccine market are Panacea Biotec Ltd., Zydus Lifesciences, Serum Institute of India Pvt. Ltd., Bharat Biotech Ltd., Haffkine Biopharmaceutical Co. Ltd., Medigen Vaccine Biologics Corp., BlueWillow Biologics Inc.
View The Full Oral Vaccine Market Report:
Oral Vaccine Market Geographic Distribution And Regional Opportunities
North America was the largest region in the oral vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
